All articles by Phillip Broadwith – Page 10
-
OpinionHow the chemical industry is voting in the EU referendum
UK trade bodies predominantly favour remaining in the EU
-
BusinessMylan expands in dermatology
$1bn deal with Renaissance Acquisition Holdings brings 25 products and builds on Meda merger portfolio
-
Business
Total to buy Saft for battery boost
€950m deal pushes French oil giant deeper into renewables
-
OpinionHealing the world
Will GSK’s move towards licensing patents in developing countries, rather than rigidly defending them, improve access to medicines?
-
BusinessPumping up industrial wasted heat
Company profile: Qpinch reclaims wasted energy by mimicking nature
-
-
BusinessTwo dead in explosion at Chinese chemical plant
Five others injured when wastewater treatment device detonated
-
OpinionChecks and balances
Should trade bodies do more than simply ‘represent their members’ interests’?
-
BusinessRoche sketches out Blueprint collaboration
Drug discovery startup will contribute to cancer immunotherapy projects aimed at kinase enzymes
-
-
OpinionForged in righteous flames
Could the debate over pharma price-gouging have positive results for both patients and companies?
-
Business
Pfizer agrees potential $785m fraud settlement
Whistleblower case relates to claims of Wyeth overcharging for acid reflux drugs between 2001 and 2006
-
BusinessAkzoNobel to buy BASF’s industrial coatings
€475 million deal includes technology, products and sites in the UK and South Africa
-
Business
Lilly loses UK patent challenge
Allergan’s cancer drug generics do not infringe patents, say UK courts
-
Business
GSK fined for stalling antidepressant generics
UK Competition and Markets Authority deems pay-for-delay deal illegal and imposes £45m in fines
-
BusinessMedical devices consolidation continues
Abbott to buy Alere for $5.8bn to augment its point-of-care diagnostics business
-
Business
Merck & Co joins hepatitis C party
New drug adds new treatment options and increases competition in premium market
-
BusinessJ&J to cut 3000 jobs in medical devices unit
Cost-saving cuts will help ‘accelerate the pace of innovation’, company claims
-
OpinionThe kids aren’t alright
Making it more attractive for companies to develop paediatric drugs has the potential to improve everyone’s lives
-
Business
Fatal blast at US peroxide plant
One dead and three injured in an equipment explosion at PeroxyChem in Texas